Navigation Links
Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
Date:7/14/2008

- Company to Host Conference Call to Update Clinical Program -

CALGARY, July 14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has now enrolled and treated 200 cancer patients in clinical studies with REOLYSIN(R), its proprietary formulation of the human reovirus.

"The clinical program has gained substantial momentum in the past year, culminating in the treatment of our 200th patient this week," said Dr. Brad Thompson, President and CEO of Oncolytics. "REOLYSIN(R) has been well tolerated by the patients, and has demonstrated activity in all trials reported on to date. Our current studies will allow us to design our pivotal program based on Phase II data from human clinical studies."

Together with its collaborators, Oncolytics is now recruiting or enrolling patients in ten Phase I/II or Phase II clinical trials with REOLYSIN(R) in the U.S. and the U.K., and has permission to begin another Phase II trial in the U.S. These trials include four monotherapy trials using REOLYSIN(R) alone, and seven trials using REOLYSIN(R) in combination with radiation or chemotherapy.

Conference Call Details

Dr. Brad Thompson, President and CEO of Oncolytics, will host a conference call on Wednesday, July 16, 2008 at 11:30 a.m. MST (1:30 p.m. EST) to update investors on the Company's current and future clinical program for REOLYSIN(R).

To access the conference call by telephone, dial 1-416-644-3414 or 1-800-733-7571. A live audio webcast will be available through the Company's website at http://www.oncolyticsbiotech.com. Please connect at least 15 minutes prior to the webcast to ensure adequate time for any software download that may be needed. A replay of the webcast will be available at http://www.oncolyticsbiotech.com and will also be available by teleph
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
2. Oncolytics Biotech Inc. to Present at BIO 2008 International Convention
3. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
4. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
5. Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
6. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting
7. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
8. Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R)
9. Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent
10. Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting
11. Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Carahsoft and CDS ... Thursday, January 23, 2014 at 2pm EST (11am ... Actionable Knowledge.” The topic focuses on how technology ... to drive mission critical decisions for government agencies. ... , Synopsis: Big Data has become an obstacle ...
(Date:1/14/2014)... Texas , Jan. 14, 2014 ... analyze and research medicinal plants and therapeutic derivatives ... industry, health professionals, and researchers about the challenges ... (Logo: http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The ... (known by its acronym GA, based on ...
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ... safety, clinical outcomes, and medication adherence. , It ...
(Date:1/14/2014)... January 14, 2014 Independent publisher Bitingduck ... and Montreal, Canada, has big ideas for 2014 in ... press's goals are to produce high-quality, low-cost, DRM-free ebooks ... local businesses. , The first major development will ... new technology called WebBytez . WebBytez is a ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... RainDance Technologies, Inc.,a provider of innovative droplet-based ... announced that the J. Craig Venter,Institute (JCVI), a ... MD and La Jolla, CA, will become an ... and Sequence Enrichment application., Under the Early ...
... BREAKING NEWS: Paige Padgett has,been selected as one of ... Awards on November 13th at The Ebell of Los ... Blush, lipstick, eye shadow - check. Ecological impact... who ... eco-conscious often doesn,t,happen in the bathroom. Up to 60% ...
... ultra-high definition has potential to revolutionize,endoscopic surgery, ... a glimpse into the,future of women,s healthcare with ... the first time using "4K" technology, at the ... the AAGL. AAGL,is the international professional society for ...
Cached Biology Technology:RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI 2RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI 3Green Makeup Artist Paige Padgett Says, 'Get Smart' 2Women's Surgery Recorded for the First Time on '4K' Digital Cinema is Presented at the AAGL Congress 2
(Date:4/15/2014)... the question of how social behavior has developed over ... Mainz and Basel have gained new insights from the ... for food. Rather the siblings share what is available ... Dr. Jol Meunier of the Evolutionary Biology section of ... Mainz (JGU). The team of biologists from Mainz University ...
(Date:4/15/2014)... MA -- Delivering chemotherapy drugs in nanoparticle form could ... to the tumors. In recent years, scientists have developed ... it has been difficult to design particles that ... ratio. , Now MIT chemists have devised a new ... to include three or more different drugs. In a ...
(Date:4/15/2014)... that the genetic code is far more complex ... building blocks adenine, cytosine, guanine, and thymine, numerous ... assume that the newly discovered nucleic acid modifications ... extends and complements the genetic code. "The new ... standard alphabet," explained Professor Mark Helm of the ...
Breaking Biology News(10 mins):Sibling cooperation in earwig families gives clues to early evolution of social behavior 2Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3German Research Foundation approves new priority program in the life sciences 2
... Troy, N.Y. Researchers at Rensselaer Polytechnic Institute ... the first-ever virtual reality simulator for next-generation "scarless" ... the U.S. National Institutes of Health (NIH), seeks ... endoscopic surgery, or NOTES. This emerging surgical technique ...
... new genetic clues on risk factors and biological causes ... (PSP), according to a new study from an international ... of Medicine at the University of Pennsylvania. In the ... associated with risk for PSP were identified and two ...
... 2011)Mitochondria, those battery-pack organelles that fuel the energy of ... calcium. Whether in a dish or a living organism, ... compound. Because calcium levels link to many essential biological ... diabetesscientists have been working for half a century to ...
Cached Biology News:Rensselaer researchers secure $2.7 million NIH grant to advance 'scarless' surgery 2Rensselaer researchers secure $2.7 million NIH grant to advance 'scarless' surgery 3New genes for risk and progression of rare brain disease identified 2New genes for risk and progression of rare brain disease identified 350-year search for calcium channel ends 250-year search for calcium channel ends 3
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
... HDAC8 Regulation of gene expression ... as DNA methylation, ATP-dependent chromatin remodeling, ... which include the dynamic acetylation and ... residues present in the tail of ...
... raised against a partial recombinant ... SLC22A3 (NP_068812, 90 a.a. ... protein with GST tag. ... NM_021977 Protein ...
...
Biology Products: